There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.
Principal Investigator | |
Principal Investigator's Name: | Jennifer Zimmer |
Institution: | Eli Lilly & Company |
Department: | Neurodevelopment Unit |
Country: | |
Proposed Analysis: | Access will be used to provide a summary of adverse event data, discontinuations, and deaths in ADNI participants, to provide background rates for ongoing clinical trials in patients with MCI and AD dementia. In 2012, Henley et al. manuscript Safety profile Alzheimer's disease populations in Alzheimer's Disease Neuroimaging Initiative an other 18-month studies was published (Alzheimer's & Dementia 2012(8) 407-416. This article was based on ADNI date through 5 Jan 2010. The proposed analysis will be based on updated ADNI data. |
Additional Investigators |